Lexicon Pharmaceuticals

$6.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+1.80%) Today
+$0.12 (+1.77%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LXRX and other stocks, options, and ETFs commission-free!

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. The listed name for LXRX is Lexicon Pharmaceuticals, Inc. Common Stock.

CEO
Lonnel Coats
Employees
184
Headquarters
The Woodlands, Texas
Founded
1995
Market Cap
1.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.40M
High Today
$6.79
Low Today
$6.00
Open Price
$6.72
Volume
1.69M
52 Week High
$9.65
52 Week Low
$1.03

LXRX Earnings

-$0.77
-$0.27
$0.23
$0.73
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 10, After Hours

You May Also Like

CBB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure